Mariner’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-143,218
| Closed | -$159K | – | 2913 |
|
|
2022
Q4 | $159K | Sell |
143,218
-1,185
| -0.8% | -$1.32K | ﹤0.01% | 2409 |
|
|
2022
Q3 | $338K | Sell |
144,403
-172
| -0.1% | -$403 | ﹤0.01% | 1690 |
|
|
2022
Q2 | $438K | Sell |
144,575
-354
| -0.2% | -$1.07K | ﹤0.01% | 1171 |
|
|
2022
Q1 | $984K | Buy |
144,929
+180
| +0.1% | +$1.22K | ﹤0.01% | 939 |
|
|
2021
Q4 | $1.21M | Sell |
144,749
-4,714
| -3% | -$39.4K | 0.01% | 780 |
|
|
2021
Q3 | $1.11M | Buy |
149,463
+8
| +0% | +$59 | 0.01% | 677 |
|
|
2021
Q2 | $1.02M | Buy |
149,455
+58
| +0% | +$394 | 0.01% | 661 |
|
|
2021
Q1 | $1.53M | Hold |
149,397
| – | – | 0.01% | 515 |
|
|
2020
Q4 | $1.05M | Hold |
149,397
| – | – | 0.01% | 552 |
|
|
2020
Q3 | $1.22M | Sell |
149,397
-31
| -0% | -$253 | 0.01% | 466 |
|
|
2020
Q2 | $1.03M | Buy |
149,428
+31
| +0% | +$214 | 0.01% | 481 |
|
|
2020
Q1 | $710K | Buy |
+149,397
| New | +$710K | 0.01% | 528 |
|